418 results on '"Reynolds, Kerry L."'
Search Results
2. Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers
3. Cardiovascular Considerations Before Cancer Therapy: Gaps in Evidence and JACC: CardioOncology Expert Panel Recommendations
4. Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
5. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis
6. The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospitalized oncology patients
7. Acute kidney injury in patients treated with immune checkpoint inhibitors
8. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
9. Electrocardiographic features of immune checkpoint inhibitor associated myocarditis.
10. Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor�Associated Myocarditis
11. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
12. Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy
13. Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis
14. Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study
15. Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors
16. Identification of Immune Checkpoint Inhibitor–Induced Diabetes.
17. Multi-detector computed tomography (MDCT)–based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitis
18. Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
19. Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study
20. Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study
21. The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
22. Thermal Ablation, Embolization, and Selective Internal Radiation Therapy Combined with Checkpoint Inhibitor Cancer Immunotherapy: Safety Analysis
23. Liver biopsy findings in patients on immune checkpoint inhibitors
24. Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors
25. Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research
26. Musculoskeletal Ultrasound Characteristics of Checkpoint Inhibitor-Associated Inflammatory Arthritis
27. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis
28. Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
29. What the Cardiologist Needs to Know About Cancer Immunotherapies and Complications
30. A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report
31. Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort Study
32. Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor
33. Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort Study
34. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
35. Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study
36. Medication-Related Adverse Events and Discordancies in Cystatin C–Based vs Serum Creatinine–Based Estimated Glomerular Filtration Rate in Patients With Cancer
37. Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
38. Low grade cutaneous immune related adverse events leading to immunotherapy discontinuation
39. Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
40. Abstract 14600: Pre-existing Autoimmune Disease and the Risk for Cardiovascular and Non-cardiovascular Immune Mediated Adverse Events With Immune Checkpoint Inhibitors
41. Abstract 13352: Decreased Absolute Lymphocyte Count and Increased Neutrophil Lymphocyte Ratio With Immune Checkpoint Inhibitors-associated Myocarditis
42. Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
43. Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis
44. Supplementary Data from Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
45. Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations
46. Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study
47. Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy
48. Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study
49. Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade
50. Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.